Heart failure & cardiomyopathiesCohort study

Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study

ESC Heart FailPublished

  • multicentre retrospective study

Authors' conclusion

A blunted chronotropic response is common in transthyretin amyloid cardiomyopathy and conveys adverse short-term prognosis. A pHR% ≤75% represents a clinically meaningful and easily obtainable threshold for functional and prognostic stratification, offering a pragmatic alternative when comprehensive cardiopulmonary exercise testing assessment is not available.

Study context

Population
Stable outpatients with transthyretin amyloid cardiomyopathy, in sinus rhythm and naïve to disease-specific therapy, who underwent maximal cardiopulmonary exercise testingstable outpatients with transthyretin amyloid cardiomyopathy
Participants
212 outpatients
Exposure
Chronotropic response and 1-year cardiovascular mortality

Main finding

As reported in the abstract

Prevalence of chronotropic incompetence (pHR% ≤75%)

Chronotropic incompetence defined by a pHR% ≤75% present

35%

Observational data: associations, not effects.

Further findings

Outcomehazard ratioP value
Cardiovascular mortality per 1% increase in pHR% · 1 year0.945P = 0.011
  • Cardiovascular mortality per 1% increase in pHR%: 5.5% relative reduction in cardiovascular mortality risk per 1% increase

Cardiovascular deaths · 1-year follow-up

Cardiovascular deaths
10

Discrimination of pHR% threshold of 75%

area under the curve
0.71
Subgroup with significantly lower survival, log-rank
P < 0.05

Original publication

Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study. ESC Heart Fail. Published 3 July 2026. doi:10.1093/eschf/xvag170

Summarised from the published abstract; every number is checked against it